OR WAIT 15 SECS
© 2021 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
© 2021 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
January 11, 2020
Novel drugs, value-based contracting, biosimilars, and regulatory activity addressing costs will be among the hot button issues in the coming year.
January 10, 2020
Health executives weigh in on what success will mean to them in 2020.
January 09, 2020
Risk-stratification and electronic triage programs are improving patient care and decreasing costs for health systems.
January 08, 2020
Increasing chronic care needs are incentivizing direct-tech services.
January 07, 2020
Payer education, evidence critical to providing cost-effective, beneficial treatment in pharmacogenetics.
January 06, 2020
Many of the challenges that face our industry in 2020 will require a fresh way of thinking.
January 04, 2020
Here are healthcare leaders’ top challenges, as well as coping strategies
January 03, 2020
The new and proposed federal regulations, as well as state laws, that are trending across the United States.
January 02, 2020
Here are four programs making a difference.
January 01, 2020
Here are the top drugs expected to be approved this year and their financial impact.
November 04, 2019
Strategies to get the most value out of current and future oncology payment models
November 02, 2019
Leadership skills honed in midst of disaster.